Accession Number: | 0001209191-23-031243 |
Date: | 2023-05-17 |
Issuer: | ACADIA PHARMACEUTICALS INC (ACAD) |
Original Submission Date: |
SCHNEYER MARK C.
C/O ACADIA PHARMACEUTICALS INC.
12830 EL CAMINO REAL, SUITE 400
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2023-05-17 | M | 14,869 | a | $0.00 | 22,346 | direct | ||
COMMON STOCK | 2023-05-17 | M | 14,869 | a | $0.00 | 37,215 | direct | ||
COMMON STOCK | 2023-05-17 | S | 15,310 | d | $22.50 | 21,905 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
RESTRICTED STOCK UNITS | 0.0 | 2023-05-17 | deemed execution date | M | 14,869 (d) | common stock 14,869 | $0.00 | 24,782 | direct | |||
RESTRICTED STOCK UNITS | 0.0 | 2023-05-17 | deemed execution date | M | 14,869 (d) | common stock 14,869 | $0.00 | 24,782 | direct |
ID | footnote |
---|---|
f1 | each restricted stock unit represents a contingent right to receive one share of issuer's common stock. |
f2 | the sales reported in this form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units. |
f3 | the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. |
f4 | the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date. in addition, these restricted stock units may vest earlier upon the issuer's common stock achieving a specified price per share over a specified trading period. |